Grantham, Mayo, Van Otterloo & Co. LLC
- SEC CIK
- 0001352662
- Latest filing
- Aug 13, 2026
EW holding history
Edwards Lifesciences Corp in every 13F filed by Grantham, Mayo, Van Otterloo & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EW overviewAll 13F holders of EWFull Q2 2026 holdings
- Shares (Q2 2026)
- 20,664
- Value
- $1.87M
- % of portfolio
- <0.1%
- Quarters held
- 8
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 20,664 | $1.87M | <0.1% | +1,614+8.5% | Added | Holders |
| Q1 2026 | 19,050 | $1.53M | <0.1% | −15,886−45.5% | Reduced | Holders |
| Q4 2025 | 34,936 | $2.98M | <0.1% | +20,358+139.6% | Added | Holders |
| Q3 2025 | 14,578 | $1.13M | <0.1% | +14,578 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −26,591−100.0% | Sold out | Holders |
| Q1 2025 | 26,591 | $1.93M | <0.1% | +26,591 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −3,000−100.0% | Sold out | Holders |
| Q4 2022 | 3,000 | $223.8K | <0.1% | +3,000 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −6,082−100.0% | Sold out | Holders |
| Q1 2022 | 6,082 | $716.0K | <0.1% | +6,082 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −33,763−100.0% | Sold out | Holders |
| Q1 2021 | 33,763 | $2.82M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.